DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
INZOMELID
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
INZOMELID
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C19H24N4O3S
Molecular Weight:
388.49
AlogP:
2.95
PSA:
93.09
HBD:
2.0
HBA:
#RotB:
4.0
Source:
LY-3007113
1
Small molecule
Investigational
Unknown
Unknown
Unknown
MAP kinase p38 alpha inhibitor
LY-3007113
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FILOCICLOVIR
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FILOCICLOVIR
×
Maximum Phase:
1
First Approval:
None
UNII:
EAO0TD9B13
Molecule Type:
Small molecule
Molecular Formula:
C11H13N5O3
Molecular Weight:
263.26
AlogP:
-1.08
PSA:
130.05
HBD:
4.0
HBA:
#RotB:
3.0
Source:
123I-IODOMETOMIDATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
123I-IODOMETOMIDATE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
KL-1333
1
Small molecule
Investigational
Unknown
Unknown
MELAS Syndrome; Mitochondrial Diseases
Unknown
KL-1333
×
Maximum Phase:
1
First Approval:
None
UNII:
NA2ZOL5UGM
Molecule Type:
Small molecule
Molecular Formula:
C14H12N2O2
Molecular Weight:
240.26
AlogP:
2.58
PSA:
62.82
HBD:
1.0
HBA:
#RotB:
1.0
Source:
CLN-081
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Epidermal growth factor receptor erbB1 inhibitor
CLN-081
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C23H20N6O
Molecular Weight:
396.45
AlogP:
3.32
PSA:
98.72
HBD:
2.0
HBA:
#RotB:
3.0
Source:
PHE377
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Vanilloid receptor antagonist
PHE377
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RG7893
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Sodium channel protein type IX alpha subunit blocker
RG7893
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-05105679
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PF-05105679
×
Maximum Phase:
1
First Approval:
None
UNII:
F2B10OFV7Y
Molecule Type:
Small molecule
Molecular Formula:
C26H21FN2O3
Molecular Weight:
428.46
AlogP:
5.48
PSA:
70.5
HBD:
1.0
HBA:
#RotB:
6.0
Source:
ALOBRESIB
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Lymphoma; Prostatic Neoplasms, Castration-Resistant
Unknown
ALOBRESIB
×
Maximum Phase:
1
First Approval:
None
UNII:
3QBL0BLP3D
Molecule Type:
Small molecule
Molecular Formula:
C26H23N5O2
Molecular Weight:
437.5
AlogP:
4.79
PSA:
100.72
HBD:
2.0
HBA:
#RotB:
5.0
Source:
CPI-1205
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Follicular; Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
CPI-1205
×
Maximum Phase:
1
First Approval:
None
UNII:
455J2479FY
Molecule Type:
Small molecule
Molecular Formula:
C27H33F3N4O3
Molecular Weight:
518.58
AlogP:
4.72
PSA:
79.36
HBD:
2.0
HBA:
#RotB:
7.0
Source:
PEGULICIANINE ACETATE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PEGULICIANINE ACETATE
×
Maximum Phase:
1
First Approval:
None
UNII:
F3F6208UMT
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BL-1021
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BL-1021
×
Maximum Phase:
1
First Approval:
None
UNII:
7Q35V52Q2Z
Molecule Type:
Small molecule
Molecular Formula:
C23H28N2O
Molecular Weight:
348.49
AlogP:
3.8
PSA:
46.33
HBD:
1.0
HBA:
#RotB:
6.0
Source:
AS-703988
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Dual specificity mitogen-activated protein kinase kinase 1 inhibitor
AS-703988
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PEN-866
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PEN-866
×
Maximum Phase:
1
First Approval:
None
UNII:
56DL1J49LR
Molecule Type:
Small molecule
Molecular Formula:
C49H49N7O9
Molecular Weight:
879.97
AlogP:
6.97
PSA:
207.03
HBD:
4.0
HBA:
#RotB:
9.0
Source:
HEMAY-022
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms
Receptor protein-tyrosine kinase erbB-2 inhibitor
HEMAY-022
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LISAVANBULIN
1
Small molecule
Investigational
Unknown
Unknown
Glioblastoma; Neoplasms
Unknown
LISAVANBULIN
×
Maximum Phase:
1
First Approval:
None
UNII:
5PT0QP06X5
Molecule Type:
Small molecule
Molecular Formula:
C26H29N9O3
Molecular Weight:
515.58
AlogP:
2.69
PSA:
190.77
HBD:
4.0
HBA:
#RotB:
13.0
Source:
CEP-5214
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Vascular endothelial growth factor receptor inhibitor
CEP-5214
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C28H28N2O3
Molecular Weight:
440.54
AlogP:
4.92
PSA:
63.49
HBD:
2.0
HBA:
#RotB:
6.0
Source:
AZD3043
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AZD3043
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
VNRX-7145
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
VNRX-7145
×
Maximum Phase:
1
First Approval:
None
UNII:
C5F376EKS2
Molecule Type:
Small molecule
Molecular Formula:
C19H26BNO7
Molecular Weight:
391.23
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
DTP-348
1
Small molecule
Investigational
Unknown
Unknown
Head and Neck Neoplasms
Unknown
DTP-348
×
Maximum Phase:
1
First Approval:
None
UNII:
2HB46A9CNM
Molecule Type:
Small molecule
Molecular Formula:
C6H11N5O4S
Molecular Weight:
249.25
AlogP:
-1.11
PSA:
133.15
HBD:
2.0
HBA:
#RotB:
5.0
Source:
DEFERITRIN
1
Small molecule
Investigational
Unknown
Unknown
beta-Thalassemia
Unknown
DEFERITRIN
×
Maximum Phase:
1
First Approval:
None
UNII:
T69Y9LDN44
Molecule Type:
Small molecule
Molecular Formula:
C11H11NO4S
Molecular Weight:
253.28
AlogP:
1.43
PSA:
90.12
HBD:
3.0
HBA:
#RotB:
2.0
Source:
GAMITRINIB
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma
Unknown
GAMITRINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C53H67N3O8P+
Molecular Weight:
905.11
AlogP:
7.3
PSA:
166.28
HBD:
4.0
HBA:
#RotB:
14.0
Source:
RODATRISTAT ETHYL
1
Small molecule
Investigational
Unknown
Unknown
Hypertension, Pulmonary
Tryptophan 5-hydroxylase 1 inhibitor
RODATRISTAT ETHYL
×
Maximum Phase:
1
First Approval:
None
UNII:
507FY6OL37
Molecule Type:
Small molecule
Molecular Formula:
C29H31ClF3N5O3
Molecular Weight:
590.05
AlogP:
5.57
PSA:
102.6
HBD:
2.0
HBA:
#RotB:
7.0
Source:
VELSECORAT
1
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive; Asthma
Unknown
VELSECORAT
×
Maximum Phase:
1
First Approval:
None
UNII:
P30N0911C2
Molecule Type:
Small molecule
Molecular Formula:
C32H32F2N4O6
Molecular Weight:
606.63
AlogP:
4.6
PSA:
112.94
HBD:
2.0
HBA:
#RotB:
9.0
Source:
COMBRETASTATIN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
COMBRETASTATIN
×
Maximum Phase:
1
First Approval:
None
UNII:
7O62J06F18
Molecule Type:
Small molecule
Molecular Formula:
C18H22O6
Molecular Weight:
334.37
AlogP:
2.7
PSA:
77.38
HBD:
2.0
HBA:
#RotB:
7.0
Source:
HYMECROMONE
1
Small molecule
Investigational
Unknown
Unknown
Respiratory Tract Diseases
Unknown
HYMECROMONE
×
Maximum Phase:
1
First Approval:
None
UNII:
3T5NG4Q468
Molecule Type:
Small molecule
Molecular Formula:
C10H8O3
Molecular Weight:
176.17
AlogP:
1.81
PSA:
50.44
HBD:
1.0
HBA:
#RotB:
0.0
Source:
ZOTATIFIN
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Severe Acute Respiratory Syndrome
Unknown
ZOTATIFIN
×
Maximum Phase:
1
First Approval:
None
UNII:
2EWN8Z05CN
Molecule Type:
Small molecule
Molecular Formula:
C28H29N3O5
Molecular Weight:
487.56
AlogP:
2.78
PSA:
108.07
HBD:
2.0
HBA:
#RotB:
6.0
Source:
VLX-1005
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
VLX-1005
×
Maximum Phase:
1
First Approval:
None
UNII:
JKU4XCC48Y
Molecule Type:
Small molecule
Molecular Formula:
C21H19N3O4S2
Molecular Weight:
441.53
AlogP:
4.42
PSA:
100.55
HBD:
3.0
HBA:
#RotB:
7.0
Source:
8-CHLOROADENOSINE
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Unknown
8-CHLOROADENOSINE
×
Maximum Phase:
1
First Approval:
None
UNII:
PA05MFH3I7
Molecule Type:
Small molecule
Molecular Formula:
C10H12ClN5O4
Molecular Weight:
301.69
AlogP:
-1.33
PSA:
139.54
HBD:
4.0
HBA:
#RotB:
2.0
Source:
FEDOVAPAGON
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FEDOVAPAGON
×
Maximum Phase:
1
First Approval:
None
UNII:
VX2GBO4I0V
Molecule Type:
Small molecule
Molecular Formula:
C27H34N4O3
Molecular Weight:
462.59
AlogP:
3.74
PSA:
72.96
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ROLUPERIDONE HYDROCHLORIDE
1
Small molecule
Investigational
Unknown
Unknown
Schizophrenia
Unknown
ROLUPERIDONE HYDROCHLORIDE
×
Maximum Phase:
1
First Approval:
None
UNII:
WFL7TF8DTP
Molecule Type:
Small molecule
Molecular Formula:
C22H28ClFN2O4
Molecular Weight:
438.93
AlogP:
3.38
PSA:
40.62
HBD:
0.0
HBA:
#RotB:
5.0
Source:
LY-2886721
1
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Unknown
LY-2886721
×
Maximum Phase:
1
First Approval:
None
UNII:
2CQ62IWB67
Molecule Type:
Small molecule
Molecular Formula:
C18H16F2N4O2S
Molecular Weight:
390.42
AlogP:
2.52
PSA:
89.6
HBD:
2.0
HBA:
#RotB:
3.0
Source:
VS-4718
1
Small molecule
Investigational
Unknown
Unknown
Leukemia, Biphenotypic, Acute; Leukemia, Myeloid, Acute; Pancreatic Neoplasms
Focal adhesion kinase 1 inhibitor
VS-4718
×
Maximum Phase:
1
First Approval:
None
UNII:
L2BD0MW4OL
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BIIB-028
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
Unknown
BIIB-028
×
Maximum Phase:
1
First Approval:
None
UNII:
KD4GWWK597
Molecule Type:
Small molecule
Molecular Formula:
C19H21ClN5O5P
Molecular Weight:
465.83
AlogP:
2.59
PSA:
145.61
HBD:
3.0
HBA:
#RotB:
6.0
Source:
1
2
…
63
64
65
66
67
68
69
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA